Form 483

Pharmaceutics International, Inc. Form 483, 2013-09-13

FDA issued a Form 483 to Pharmaceutics International, Inc. on 2013-09-13 with 10 public-safe observations.

483· Form 483 issuedHuman Drugs10 observations

Pharmaceutics International, Inc. · Cockeysville, United States · Issued September 13, 2013

Overview

  • 10 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

13 Sep 2013
21 CFR 211.42(c)(10)(iii)

Air Supply

Cited by Rachel C Harrington

13 Sep 2013
21 CFR 211.42(c)(10)(iv)

Environmental Monitoring System

Cited by Rachel C Harrington

13 Sep 2013
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Rachel C Harrington

13 Sep 2013
21 CFR 211.68(b)

input/output verification

Cited by Rachel C Harrington

13 Sep 2013
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Rachel C Harrington

Inspected site

PIPharmaceutics International, Inc.Cockeysville, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations2x
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.188Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iii)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 10 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere